BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Houen G, Trier NH. Epstein-Barr Virus and Systemic Autoimmune Diseases. Front Immunol 2020;11:587380. [PMID: 33488588 DOI: 10.3389/fimmu.2020.587380] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Mahroum N, Zoubi M, Lavine N, Ohayon A, Amital H, Shoenfeld Y. The mosaic of autoimmunity - A taste for more. The 12th international congress of autoimmunity 2021 (AUTO12) virtual. Autoimmun Rev 2021;20:102945. [PMID: 34509655 DOI: 10.1016/j.autrev.2021.102945] [Reference Citation Analysis]
2 Wang J, Li Y, Geng X, Zhang X, Xiao Y, Wang W. Associations of Epstein-Barr Virus Infection with Attention Deficit Hyperactivity Disorder, Learning Disability, and Special Education in US Children. IJGM 2022;Volume 15:2187-95. [DOI: 10.2147/ijgm.s355263] [Reference Citation Analysis]
3 Herbert A, Fedorov A, Poptsova M. Mono a Mano: ZBP1’s Love–Hate Relationship with the Kissing Virus. IJMS 2022;23:3079. [DOI: 10.3390/ijms23063079] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Paganelli R. Resurrecting Epstein–Barr Virus. Pathogens 2022;11:772. [DOI: 10.3390/pathogens11070772] [Reference Citation Analysis]
5 Rozman M, Korać P, Jambrosic K, Židovec Lepej S. Progress in Prophylactic and Therapeutic EBV Vaccine Development Based on Molecular Characteristics of EBV Target Antigens. Pathogens 2022;11:864. [DOI: 10.3390/pathogens11080864] [Reference Citation Analysis]
6 Enfrein A, Hamidou M. Epstein-Barr Virus et lupus systémique : quels liens ? La Revue de Médecine Interne 2022. [DOI: 10.1016/j.revmed.2022.03.341] [Reference Citation Analysis]
7 Zhang J, Li Y, Wan J, Zhang M, Li C, Lin J. Artesunate: A review of its therapeutic insights in respiratory diseases. Phytomedicine 2022;104:154259. [PMID: 35849970 DOI: 10.1016/j.phymed.2022.154259] [Reference Citation Analysis]
8 Zubchenko S, Kril I, Nadizhko O, Matsyura O, Chopyak V. Herpesvirus infections and post-COVID-19 manifestations: a pilot observational study. Rheumatol Int 2022. [PMID: 35650445 DOI: 10.1007/s00296-022-05146-9] [Reference Citation Analysis]
9 Noonan TP, Konstantinov KN, Echevarria L. Epstein-Barr virus reactivation induced myeloperoxidase-specific antineutrophil cytoplasmic antibody (MPO-ANCA)-associated vasculitis. BMJ Case Rep 2021;14:e245059. [PMID: 34620637 DOI: 10.1136/bcr-2021-245059] [Reference Citation Analysis]
10 Ikeda S, Sugihara T, Kihara T, Hoshino Y, Matsuki Y, Nagahara T, Oyama K, Okano J, Kuwamoto S, Horie Y, Isomoto H. Chronic Active Epstein–Barr Virus Infection Indistinguishable from Autoimmune Hepatitis: A Case Report. Yonago Acta Med . [DOI: 10.33160/yam.2022.05.003] [Reference Citation Analysis]
11 Wu M, Li SX, Xue P, Zhou J, Tang X. COVID-19 Vaccine Could Trigger the Relapse of Secondary Hypersomnia. Nat Sci Sleep 2021;13:2267-71. [PMID: 35002346 DOI: 10.2147/NSS.S345801] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Zhang N, Zuo Y, Jiang L, Peng Y, Huang X, Zuo L. Epstein-Barr Virus and Neurological Diseases. Front Mol Biosci 2022;8:816098. [DOI: 10.3389/fmolb.2021.816098] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
13 Escalante GM, Mutsvunguma LZ, Muniraju M, Rodriguez E, Ogembo JG. Four Decades of Prophylactic EBV Vaccine Research: A Systematic Review and Historical Perspective. Front Immunol 2022;13:867918. [DOI: 10.3389/fimmu.2022.867918] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Zarghami A, Li Y, Claflin SB, van der Mei I, Taylor BV. Role of environmental factors in multiple sclerosis. Expert Rev Neurother 2021;:1-20. [PMID: 34494502 DOI: 10.1080/14737175.2021.1978843] [Reference Citation Analysis]
15 Gold JE, Okyay RA, Licht WE, Hurley DJ. Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation. Pathogens 2021;10:763. [PMID: 34204243 DOI: 10.3390/pathogens10060763] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
16 Afrasiabi A, Keane JT, Ong LTC, Alinejad-Rokny H, Fewings NL, Booth DR, Parnell GP, Swaminathan S. Genetic and transcriptomic analyses support a switch to lytic phase in Epstein Barr virus infection as an important driver in developing Systemic Lupus Erythematosus. J Autoimmun 2021;127:102781. [PMID: 34952359 DOI: 10.1016/j.jaut.2021.102781] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Alsaegh MA, Mahmoud O, Varma SR, Zhu S. The Prevalence of EBV and KSHV in Odontogenic Lesions. Int Dent J 2022:S0020-6539(22)00173-3. [PMID: 35907672 DOI: 10.1016/j.identj.2022.06.028] [Reference Citation Analysis]
18 Umakanthan S, Bukelo MM. Molecular Genetics in Epstein-Barr Virus-Associated Malignancies. Life (Basel) 2021;11:593. [PMID: 34206255 DOI: 10.3390/life11070593] [Reference Citation Analysis]
19 Maple PA, Ascherio A, Cohen JI, Cutter G, Giovannoni G, Shannon-lowe C, Tanasescu R, Gran B. The Potential for EBV Vaccines to Prevent Multiple Sclerosis. Front Neurol 2022;13:887794. [DOI: 10.3389/fneur.2022.887794] [Reference Citation Analysis]
20 Ergunay K, Mutinda M, Bourke B, Justi SA, Caicedo-quiroga L, Kamau J, Mutura S, Akunda IK, Cook E, Gakuya F, Omondi P, Murray S, Zimmerman D, Linton Y. Metagenomic Investigation of Ticks From Kenyan Wildlife Reveals Diverse Microbial Pathogens and New Country Pathogen Records. Front Microbiol 2022;13:932224. [DOI: 10.3389/fmicb.2022.932224] [Reference Citation Analysis]
21 Banko A, Miljanovic D, Lazarevic I, Jeremic I, Despotovic A, Grk M, Cirkovic A. New Evidence of Significant Association between EBV Presence and Lymphoproliferative Disorders Susceptibility in Patients with Rheumatoid Arthritis: A Systematic Review with Meta-Analysis. Viruses 2022;14:115. [PMID: 35062319 DOI: 10.3390/v14010115] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
22 Hong X, Wang X, Rang X, Yin X, Zhang X, Wang R, Wang D, Zhao T, Fu J. The Shared Mechanism and Candidate Drugs of Multiple Sclerosis and Sjögren's Syndrome Analyzed by Bioinformatics Based on GWAS and Transcriptome Data. Front Immunol 2022;13:857014. [PMID: 35356004 DOI: 10.3389/fimmu.2022.857014] [Reference Citation Analysis]
23 Lee J, Lee HS, Chu K. Successful treatment with rituximab for central nervous system vasculitis caused by Epstein-Barr virus-associated lymphoproliferative disorder with immunoglobulin M gammopathy. encephalitis 2022;2:14-8. [DOI: 10.47936/encephalitis.2021.00143] [Reference Citation Analysis]
24 Qing J, Song W, Tian L, Samuel SB, Li Y, Wan C. Potential Small Molecules for Therapy of Lupus Nephritis Based on Genetic Effect and Immune Infiltration. BioMed Research International 2022;2022:1-16. [DOI: 10.1155/2022/2259164] [Reference Citation Analysis]
25 Fanelli I, Rovero P, Hansen PR, Frederiksen JL, Houen G, Trier NH. Reactivity of Rheumatoid Arthritis-Associated Citrulline-Dependent Antibodies to Epstein-Barr Virus Nuclear Antigen1-3. Antibodies 2022;11:20. [DOI: 10.3390/antib11010020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Chen CC, Hung YM, Chiu LT, Chou MC, Chang R, Wei JC. Association Between Severity of Leptospirosis and Subsequent Major Autoimmune Diseases: A Nationwide Observational Cohort Study. Front Immunol 2021;12:721752. [PMID: 34566978 DOI: 10.3389/fimmu.2021.721752] [Reference Citation Analysis]
27 Sugrue JA, Bourke NM, O'Farrelly C. Type I Interferon and the Spectrum of Susceptibility to Viral Infection and Autoimmune Disease: A Shared Genomic Signature. Front Immunol 2021;12:757249. [PMID: 34917078 DOI: 10.3389/fimmu.2021.757249] [Reference Citation Analysis]
28 Qian J, Xu H. COVID-19 Disease and Dermatomyositis: A Mini-Review. Front Immunol 2021;12:747116. [PMID: 35095837 DOI: 10.3389/fimmu.2021.747116] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
29 Sepúlveda N, Malato J, Sotzny F, Grabowska AD, Fonseca A, Cordeiro C, Graça L, Biecek P, Behrends U, Mautner J, Westermeier F, Lacerda EM, Scheibenbogen C. Revisiting IgG Antibody Reactivity to Epstein-Barr Virus in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Its Potential Application to Disease Diagnosis. Front Med 2022;9:921101. [DOI: 10.3389/fmed.2022.921101] [Reference Citation Analysis]
30 Foti C, Favoino E, Scarasciulli M, Colacicco AM, Jahantigh H, Stufano A, Lovreglio P, Mascia P, Barlusconi C, Perosa F, Romita P, Calvario A. Chronic-Relapsing cutaneous leukocytoclastic vasculitis in a young patient with reduced EBV-specific T cell response using enzyme-linked immunospot (ELISPOT) assay successfully treated with Valaciclovir. IDCases 2021;26:e01331. [PMID: 34840952 DOI: 10.1016/j.idcr.2021.e01331] [Reference Citation Analysis]
31 Svendsen AJ, Westergaard MCW, Draborg AH, Holst R, Kyvik KO, Jakobsen MA, Junker P, Houen G. Altered Antibody Response to Epstein-Barr Virus in Patients With Rheumatoid Arthritis and Healthy Subjects Predisposed to the Disease. A Twin Study. Front Immunol 2021;12:650713. [PMID: 33777048 DOI: 10.3389/fimmu.2021.650713] [Reference Citation Analysis]
32 Hoch VB, Kohler AF, Augusto DG, Lobo-alves SC, Malheiros D, Cipolla GA, Boldt ABW, Braun-prado K, Wittig M, Franke A, Pföhler C, Worm M, van Beek N, Goebeler M, Sárdy M, Ibrahim S, Busch H, Schmidt E, Hundt JE, Araujo-souza PSD, Petzl-erler ML. Genetic Associations and Differential mRNA Expression Levels of Host Genes Suggest a Viral Trigger for Endemic Pemphigus Foliaceus. Viruses 2022;14:879. [DOI: 10.3390/v14050879] [Reference Citation Analysis]
33 Sausen DG, Bhutta MS, Gallo ES, Dahari H, Borenstein R. Stress-Induced Epstein-Barr Virus Reactivation. Biomolecules 2021;11:1380. [PMID: 34572593 DOI: 10.3390/biom11091380] [Reference Citation Analysis]
34 Hinrichs AC, Blokland SLM, Kruize AA, Lafeber FPJ, Leavis HL, van Roon JAG. CCL5 Release by CCR9+ CD8 T Cells: A Potential Contributor to Immunopathology of Primary Sjögren's Syndrome. Front Immunol 2022;13:887972. [PMID: 35720379 DOI: 10.3389/fimmu.2022.887972] [Reference Citation Analysis]
35 Pott F, Postmus D, Brown RJP, Wyler E, Neumann E, Landthaler M, Goffinet C. Single-cell analysis of arthritogenic alphavirus-infected human synovial fibroblasts links low abundance of viral RNA to induction of innate immunity and arthralgia-associated gene expression. Emerg Microbes Infect 2021;10:2151-68. [PMID: 34723780 DOI: 10.1080/22221751.2021.2000891] [Reference Citation Analysis]